Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 124249 Ointment in Chronic Hand Eczema
NCT02664805Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic hand eczema (CHE) comparing LEO 124249 ointment with LEO 124249 ointment vehicle (2 arms). Primary endpoint: Physician's Global Assessment Treatment Success at 56 days. Started Feb 2016; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT02664805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664805.